Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's 22nd Annual Global Investment Conference September 14-16, 2020
Arcadia Biosciences (Nasdaq: RKDA) will present at the 22nd Annual Global Investment Conference hosted by H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Arcadia Biosciences (Nasdaq: RKDA) will present at the 22nd Annual Global Investment Conference hosted by H.C. Wainwright, taking place virtually from September 14-16, 2020. The company's president and CEO, Matthew Plavan, will deliver a business overview on September 16, 2020, at 2:00 p.m. EDT. Investors can register for one-on-one meetings. The presentation will be available via a live webcast, with a replay accessible on Arcadia's website. Arcadia focuses on enhancing crop quality and nutritional value through innovative agricultural practices.
Details
News Market Reaction – RKDA
The recorded move for RKDA in the trading session of this news was +1.34%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DAVIS, Calif., Sept. 9, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be featured as a presenting company at the 22nd Annual Global Investment Conference sponsored by H.C Wainwright. The conference is being held virtually on September 14-16, 2020.
Matthew Plavan, Arcadia's president and CEO will present a business overview at 2:00 p.m. EDT on Wednesday, September 16, 2020 and will be available for one-on-one web meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hccwevents.com.
The presentation will be webcast live here, and a replay will be available in the Investors section of the company's website.
About Arcadia Biosciences
Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients. The company's GoodHempTM seed catalog delivers genetically superior hemp seeds, clones, transplants and extracts, applying the company's proprietary crop innovation technology, ArcaTech™, to an emerging crop. The company's GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Arcadia's agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. For more information, visit www.arcadiabio.com.
LinkedIn: Arcadia Biosciences
Twitter: @ArcadiaAg
View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-to-present-at-hc-wainwrights-22nd-annual-global-investment-conference-september-14-16-2020-301126240.html
SOURCE Arcadia Biosciences, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.